May 7, 2026 07:18AM

Mar 27, 2026 04:16PM

Mar 18, 2026 07:46AM

Mar 17, 2026 07:17AM

Feb 11, 2026 04:41PM

Jan 14, 2026 07:53AM

Jan 7, 2026 02:25PM Monte Rosa Therapeutics (GLUE) PT Raised to $31 at Jefferies

Jan 7, 2026 02:25PM

Dec 21, 2025 04:00AM

Dec 17, 2025 04:28AM

Dec 16, 2025 10:38AM

Dec 16, 2025 07:01AM

Dec 16, 2025 06:03AM

Nov 10, 2025 02:33AM Monte Rosa presents preclinical data on MRT-8102 at AHA sessions

Nov 6, 2025 07:06AM

Oct 24, 2025 07:00AM

Sep 15, 2025 12:02PM

Sep 15, 2025 08:16AM

Sep 15, 2025 07:01AM

Aug 7, 2025 07:04AM

Jun 10, 2025 07:00AM Monte Rosa Therapeutics (GLUE) Announces FDA Clearance of IND Application for MRT-8102, a NEK7-Directed Molecular Glue Degrader for the Treatment of Multiple Inflammatory Diseases

May 8, 2025 07:05AM

Apr 28, 2025 07:05AM

Mar 20, 2025 09:39AM

Mar 20, 2025 07:04AM

Jan 10, 2025 07:05AM

Dec 13, 2024 07:00AM

Dec 11, 2024 07:02AM Monte Rosa Therapeutics (GLUE) Presents Preclinical Data

Dec 5, 2024 07:04AM

Nov 7, 2024 07:23AM

Nov 7, 2024 07:05AM

Oct 28, 2024 02:06PM

Oct 28, 2024 12:25PM

Oct 28, 2024 07:01AM

Oct 23, 2024 07:07AM Monte Rosa Therapeutics (GLUE) Presents Preclinical Data at the 36th EORTC-NCI-AACR Symposium on the Potential of its Cyclin E1-directed Molecular Glue Degraders for the Treatment of CCNE1-Amplified S

Aug 19, 2024 07:01AM

Aug 8, 2024 07:13AM

Jun 28, 2024 10:41AM

Jun 28, 2024 07:55AM

Jun 27, 2024 07:06AM

Jun 17, 2024 08:10AM

Jun 14, 2024 08:46AM Monte Rosa Therapeutics (GLUE) Presents Preclinical Data at EULAR 2024 Demonstrating Therapeutic Potential of MRT-6160 for the Treatment of Rheumatoid Arthritis

408,509 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All